Title: Abstracts of the 5th World Stroke Conference
Abstract: HomeStrokeVol. 35, No. 6Abstracts of the 5th World Stroke Conference Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAbstracts of the 5th World Stroke Conference Originally published7 Apr 2018https://doi.org/10.1161/str.35.6.e293Stroke. 2004;35:e293–e309 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByPrinz V, Laufs U, Gertz K, Kronenberg G, Balkaya M, Leithner C, Lindauer U and Endres M (2007) Intravenous Rosuvastatin for Acute Stroke Treatment, Stroke, 39:2, (433-438), Online publication date: 1-Feb-2008.Álvarez-Sabín J, Huertas R, Quintana M, Rubiera M, Delgado P, Ribó M, Molina C and Montaner J (2007) Prior Statin Use May Be Associated With Improved Stroke Outcome After Tissue Plasminogen Activator, Stroke, 38:3, (1076-1078), Online publication date: 1-Mar-2007.Montaner J (2006) Response to Letter by Topakian et al, Stroke, 37:10, (2455-2456), Online publication date: 1-Oct-2006.Streifler J (2004) Editorial Comment—Statins, Stroke Outcome, and Stroke Prevention: When Should We Start Treatment?, Stroke, 35:5, (1121-1123), Online publication date: 1-May-2004. June 2004Vol 35, Issue 6 Advertisement Article InformationMetrics https://doi.org/10.1161/str.35.6.e293 Originally publishedApril 7, 2018 PDF download Advertisement